|
2024
|
Invention
|
3, 7-diamino-10h-phenothiazine salts and their use. Described are methods of preparing reduced 3,... |
|
|
Invention
|
Diaminophenothiazine for the treatment of microvascular brain disease disease. The invention prov... |
|
2023
|
Invention
|
Methods of synthesis and/or purification of diaminophenothiazinium compounds.
Disclosed are meth... |
|
|
Invention
|
Novel formulations and vehicles. The invention provides different types of floating composition o... |
|
|
Invention
|
Thiazole derivatives as tau aggregation inhibitors. The present invention provides compounds of g... |
|
|
Invention
|
Diagnosis of dementia |
|
|
Invention
|
Diagnosis of dementia. Diagnosis of dementia A method for diagnosing dementia subtypes is describ... |
|
|
Invention
|
Treatment of neurodegenerative disorders utilising methylthioninium (mt)-containing compounds. Th... |
|
|
Invention
|
Administration and dosage of diaminophenothiazines. The invention provides novel regimens for tre... |
|
|
Invention
|
Methylene blue containing compounds for the treatment of methaemoglobinaemia. The invention provi... |
|
2022
|
Invention
|
Method of predicting adas-cog score.
A method for predicting a patient or patient cohort's cogni... |
|
|
Invention
|
Method of predicting adas-cog score. A method for predicting a patient or patient cohort's cognit... |
|
|
Invention
|
Optimised dosage of diaminophenothiazines in populations. The invention provides novel dosing reg... |
|
2021
|
Invention
|
Phenothiazine diaminium salts and their use. Disclosed are compounds of general formula (I):
an... |
|
|
Invention
|
System. The present invention provides a system for the study of tau protein aggregation in neuro... |
|
|
Invention
|
Anti-tau antibodies. The invention relates to specific binding molecules, such as antibodies, dir... |
|
|
Invention
|
Methods of providing modulators of tau aggregation. The present invention relates generally to me... |
|
|
Invention
|
Methods of synthesis and/or purification of diaminophenothiazinium compounds. Disclosed are metho... |
|
|
Invention
|
Methylthioninium compounds for use in the treatment of covid-19.
T he present invention provides... |
|
|
Invention
|
Methylthioninium compounds for use in the treatment of covid-19.
The present invention provides ... |
|
|
Invention
|
Methylthioninium compounds for use in the treatment of hypoxemia.
The present invention provides... |
|
|
Invention
|
Methylthioninium compounds for use in the treatment of hypoxemia. The present invention provides ... |
|
|
Invention
|
Methylthioninium compounds for use in the treatment of covid-19. The present invention provides m... |
|
2020
|
Invention
|
Therapeutic interactions of leucomethylthioninium.
The present invention relates generally to me... |
|
|
Invention
|
Therapeutic interactions of leucomethylthioninium. The present invention relates generally to met... |
|
|
Invention
|
Methylthioninium for use in the treatment of synaptopathies.
The present invention relates gener... |
|
|
Invention
|
Methylthioninium as enhancers of the cognitive function.
The present invention relates generally... |
|
|
Invention
|
Methylthioninium as enhancers of the cognitive function. The present invention relates generally ... |
|
|
Invention
|
Methylthioninium for use in the treatment of synaptopathies. The present invention relates genera... |
|
2019
|
Invention
|
Medical methods utilising high purity diaminophenothiazinium compounds. This disclosure pertains ... |
|
|
Invention
|
Optimised dosage of diaminophenothiazines in populations. The invention provides novel dosi... |
|
|
Invention
|
Therapeutic use of diaminophenothiazines.
Described are methods and materials for use in the tre... |
|
2018
|
Invention
|
Network methods for neurodegenerative diseases. A method of determining patient response to a neu... |
|
2017
|
Invention
|
Synthesis of a thiosulfonic acid by a step of periodate mediated oxidative coupling of a thiosulf... |
|
|
Invention
|
Treatment of dementia. The invention describes improved treatments for Frontotemporal dementia ba... |
|
2015
|
P/S
|
Pharmaceutical and medical preparations; chemical
preparations for medical and pharmaceutical pu... |
|
|
P/S
|
Pharmaceutical and medical preparations for the treatment of diseases, illnesses and ailments in ... |
